Gregory Goodwin Pincus(Redirected from Gregory Pincus) Gregory Goodwin PincusGregory Goodwin Pincus (April 9, 1903 - August 22, 1967), American physician, biologist, and researcher, was co-inventor of the contraceptive pill. Pincus began studying hormonal biology and steroidal hormones early in his career. He was instrumental in persuading Searle to fund this research, at a time when Pfizer and Parke-Davis were reluctant to fund human trials. Pincus's first breakthrough came early, when he was able to produce in vitro fertilization in rabbits in 1934. His experiments involving parthenogenesis produced a rabbit that appeared on the cover of Look magazine in 1937 and led to his dismissal from Harvard University. In 1953, Margaret Sanger and Katherine McCormick sought out Pincus for a project involving contraception. Pincus, along with Min-Chueh Chang, investigated and established that progesterone would act as an inhibitor to ovulation. However, despite early success in preventing ovulation, and therefore fertilization, a study with beagle dogs that had been on the pill for three years showed an incidence of breast tissue nodules. Pincus had to establish long term safety, as well as efficacy, of his progesterone contraceptive. In order to prove the safety of "the pill," human trials had to be conducted. These were initiated on medical students and institutionalized patients in Massachusetts. There was a high incidence of side effects, which led to the Massachusetts trials being abandoned when the women refused to continue taking the contraceptive. Puerto Rico was selected as a trial site in 1954, in part because there was an existing network of 67 birth control clinics servicing low-income women on the island. Trails began there in 1956 and were supervised by Dr. Edris Rice-Wray. Women, once again, experienced severe side effects from "the pill" (Envoid). Rice-Wray wrote Pincus and reported that Envoid "gives one hundred percent protection against pregnancy" but causes "too many side reactions to be acceptable". Pincus disagreed. The trails went on and were expanded to Haiti, despite high attrition rates, due to the large number of women eager to try this form of contraception. In May 1960, the FDA approved Envoid for contraceptive use. Pincus's successes led to Searle introducing the first widely available oral contraceptive ("the pill"). The social, religious, ethical, and medical ramifications of this discovery are still being felt throughout the world, and his discoveries also led to the burgeoning sciences of steroidal hormone research, sex hormone research, and new forms of oncology. Pincus's work may be some of the most influential science of the twentieth century. See also: A&E's Biography of the Millennium References
This page about Gregory Pincus includes information from a Wikipedia article. Additional articles about Gregory Pincus News stories about Gregory Pincus External links for Gregory Pincus Videos for Gregory Pincus Wikis about Gregory Pincus Discussion Groups about Gregory Pincus Blogs about Gregory Pincus Images of Gregory Pincus |
|
See also: A&E's Biography of the Millennium. He continues to walk seldomly, but his increased number of base-hits has begun to compensate for this. Pincus's work may be some of the most influential science of the twentieth century. Iztúris has good speed but very little power. The social, religious, ethical, and medical ramifications of this discovery are still being felt throughout the world, and his discoveries also led to the burgeoning sciences of steroidal hormone research, sex hormone research, and new forms of oncology. A switch-hitter, he is better from the right side. Pincus's successes led to Searle introducing the first widely available oral contraceptive ("the pill"). Iztúris' greatest strengths are spectacular defense and solid contact hitting. In May 1960, the FDA approved Envoid for contraceptive use. At the end of the season he earned his first Gold Glove. The trails went on and were expanded to Haiti, despite high attrition rates, due to the large number of women eager to try this form of contraception. After two years of barely adequate hitting (though compensated by his stellar glovework), he improved markedly in 2004, when he hit .288 with 62 RBI and 25 stolen bases in 159 games. Pincus disagreed. But he showed no patience at plate, resulting in a decline in average and very few walks. Rice-Wray wrote Pincus and reported that Envoid "gives one hundred percent protection against pregnancy" but causes "too many side reactions to be acceptable". Iztúris was designated as the everyday starting shortstop from Opening Day of the 2002 season, and he quickly established himself in the Dodgers' infield. Women, once again, experienced severe side effects from "the pill" (Envoid). After showing some hitting potential with a .269 average in his rookie season with Toronto, the Dodgers were enthusiastic to trade for him. Edris Rice-Wray. Coming from a long tradition of Venezuelan shortstops, which includes Chico Carrasquel, Luis Aparicio, Dave Concepción, Ozzie Guillén, Omar Vizquel, Alex González and Carlos Guillén, Iztúris has the defensive skills to rank in such distinguished company. Trails began there in 1956 and were supervised by Dr. He made his debut with Toronto in 2001 and was traded to the Dodgers at the end of the season. Puerto Rico was selected as a trial site in 1954, in part because there was an existing network of 67 birth control clinics servicing low-income women on the island. Iztúris was signed by the Toronto Blue Jays as an amateur free agent in 1996. There was a high incidence of side effects, which led to the Massachusetts trials being abandoned when the women refused to continue taking the contraceptive. He is the half brother of shortstop Maicer Izturis. These were initiated on medical students and institutionalized patients in Massachusetts. César Iztúris [THAY-sar iz-TO-rees] (born February 10, 1980 in Barquisimeto, Lara State, Venezuela) is a Major League Baseball shortstop who plays for the Los Angeles Dodgers. In order to prove the safety of "the pill," human trials had to be conducted. Gold Glove Award (2004). Pincus had to establish long term safety, as well as efficacy, of his progesterone contraceptive. All-Star (2005). However, despite early success in preventing ovulation, and therefore fertilization, a study with beagle dogs that had been on the pill for three years showed an incidence of breast tissue nodules. Pincus, along with Min-Chueh Chang, investigated and established that progesterone would act as an inhibitor to ovulation. In 1953, Margaret Sanger and Katherine McCormick sought out Pincus for a project involving contraception. His experiments involving parthenogenesis produced a rabbit that appeared on the cover of Look magazine in 1937 and led to his dismissal from Harvard University. Pincus's first breakthrough came early, when he was able to produce in vitro fertilization in rabbits in 1934. He was instrumental in persuading Searle to fund this research, at a time when Pfizer and Parke-Davis were reluctant to fund human trials. Pincus began studying hormonal biology and steroidal hormones early in his career. Gregory Goodwin Pincus (April 9, 1903 - August 22, 1967), American physician, biologist, and researcher, was co-inventor of the contraceptive pill. ISBN 080903817X. New York: Hill and Wang, A Division of Farrar, Strauss and Giroux. Devices and Desires. Tone, Andrea (2001). ISBN 0520232585. Los Angeles: University of California Press. Imperialism in Puerto Rico. Reproducing Empire: Race, Sex, Science, and U.S. Briggs, Laura (2002). |